Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-squamous Metastatic Non-Small-Cell Lung Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Active Not RecruitingNCT05736731
What this trial is testing

Evaluate the Safety and Efficacy of A2B530, a Logic-gated CAR T, in Participants With Solid Tumors That Express CEA and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultSolid TumorPancreatic Cancer+13 more
A2 Biotherapeutics Inc. 160
Testing effectiveness (Phase 2)Looking for participantsNCT05785741
What this trial is testing

DB-1310 in Advanced/Metastatic Solid Tumors

Who this might be right for
Advanced Solid Tumor
DualityBio Inc. 1,000
Testing effectiveness (Phase 2)Study completedNCT02409368
What this trial is testing

An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 812
Large-scale testing (Phase 3)Ended earlyNCT01244191
What this trial is testing

Tivantinib Plus Erlotinib Versus Placebo Plus Erlotinib for the Treatment of Non-squamous, Non-small-cell Lung Cancer

Who this might be right for
Non Squamous, Non-small-cell Lung Cancer
Daiichi Sankyo 1,048
Early research (Phase 1)Looking for participantsNCT07503808
What this trial is testing

IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types

Who this might be right for
Esophageal Squamous Cell CarcinomaHigh Grade Serous Ovarian CancerHead and Neck Squamous Cell Carcinoma+5 more
IDEAYA Biosciences 150
Early research (Phase 1)Ended earlyNCT06546553
What this trial is testing

Learn About How Different Amounts of the Study Medicine PF-07826390 Act in the Body of People With Cancer When Taken Alone or With Other Anti-cancer Medicines.

Who this might be right for
NeoplasmsNon-small-cell Lung CancerSquamous Cell Carcinoma of the Head and Neck+3 more
Pfizer 10
Early research (Phase 1)Active Not RecruitingNCT06147037
What this trial is testing

A Phase 1, Dose-escalation Study of [225Ac]-FPI-2068 in Adult Patients With Advanced Solid Tumours

Who this might be right for
Advanced Solid TumorMetastatic Colorectal CarcinomaHead and Neck Squamous Cell Carcinoma+4 more
AstraZeneca 13
Early research (Phase 1)UnknownNCT05311618
What this trial is testing

Study of NGM438 as Monotherapy and in Combination With Pembrolizumab in Advanced or Metastatic Solid Tumors

Who this might be right for
Pancreatic CancerBreast CancerGastric Cancer+13 more
NGM Biopharmaceuticals, Inc 71
Testing effectiveness (Phase 2)Study completedNCT01138163
What this trial is testing

Study of Bavituximab Plus Docetaxel in Patients With Locally Advanced or Metastatic Non-Squamous Non Small-Cell Lung Cancer

Who this might be right for
Non-small-cell Lung Cancer
Peregrine Pharmaceuticals 121
Testing effectiveness (Phase 2)UnknownNCT04846452
What this trial is testing

Sintilimab, Anlotinib Hydrochloride and Platinum-Containing Dual-Agent Chemotherapy in NSCLC

Who this might be right for
Metastatic NSCLCRecurrent NSCLCAdvanced Non-Small Cell Squamous Lung Cancer
The First Affiliated Hospital with Nanjing Medical University 40
Early research (Phase 1)Ended earlyNCT06870487
What this trial is testing

Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B-cell LymphomaClassical Hodgkin Lymphoma+3 more
Pfizer 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT05403385
What this trial is testing

Study of Inupadenant (EOS100850) With Chemotherapy as Second Line Treatment for Nonsquamous Non-small Cell Lung Cancer

Who this might be right for
Metastatic NSCLC - Non-Small Cell Lung CancerLocally Advanced NSCLC - Non-Small Cell Lung Cancer
iTeos Therapeutics 36
Testing effectiveness (Phase 2)Looking for participantsNCT07360743
What this trial is testing

Immunotherapy Without Chemotherapy for Advanced Lung Cancer Patients With High PD-L1 Levels

Who this might be right for
Non Small Cell Lung Cancer (Squamous or Non Squamous)
UNICANCER 275
Not applicableStudy completedNCT00897793
What this trial is testing

Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial Cancer

Who this might be right for
Breast CancerColorectal CancerHead and Neck Cancer+2 more
Vanderbilt-Ingram Cancer Center 25
Large-scale testing (Phase 3)Looking for participantsNCT06692738
What this trial is testing

A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 1,160
Testing effectiveness (Phase 2)Study completedNCT04609566
What this trial is testing

Brentuximab Vedotin With Pembrolizumab in Metastatic Solid Tumors

Who this might be right for
MelanomaNon-small Cell Lung CancerSquamous Cell Carcinoma of the Head and Neck
Seagen, a wholly owned subsidiary of Pfizer 161
Large-scale testing (Phase 3)Active Not RecruitingNCT03390686
What this trial is testing

A Trial to Compare the Efficacy, Safety, Pharmacokinetics and Immunogenicity of HD204 to Avastin® in Advanced Non-squamous Non-small Cell Lung Cancer Patients

Who this might be right for
Lung CancerNon-small Cell Lung Cancer
Prestige Biopharma Limited 650
Early research (Phase 1)Looking for participantsNCT05176483
What this trial is testing

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

Who this might be right for
Renal Cell Carcinoma (RCC)Metastatic Castration-Resistant Prostate Cancer (mCRPC)Urothelial Carcinoma (UC)+8 more
Exelixis 1,394
Early research (Phase 1)UnknownNCT05867303
What this trial is testing

A RC198 Study in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Who this might be right for
MelanomaUrothelial CarcinomaRenal Cell Carcinoma+3 more
RemeGen Co., Ltd. 48
Early research (Phase 1)Not Yet RecruitingNCT07272642
What this trial is testing

A Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.

Who this might be right for
ImagingColorectal CancerHead and Neck Squamous Cell Carcinoma+2 more
Radiopharm Theranostics, Ltd 16
Next Page